Circular Genomics
Latest round
- Series A
Last raised
- Dec 2025
Total raised
- $28M
Investors
- 7
About Circular Genomics
Based in New Mexico, US, and founded in 2021 by co-founders Nikolaos Mellios, Alexander Hafez, and Kosmas Karadimitriou, Circular Genomics Inc. operates as a genomics company providing diagnosis and treatment of psychiatric and neurological disorders through development of circular RNA biomarkers. In December 2025, Circular Genomics, Inc. Circular Genomics Inc. developed a product, that is a blood-based assay that analyzes circular RNA biomarkers to predict a patient's response to selective serotonin reuptake inhibitor (SSRI) antidepressants before treatment initiation. The company’s diagnostic tool expedites treatment by identifying the most effective medication, thereby increasing the likelihood of patient recovery and reducing the trial-and-error approach commonly associated with psychiatric treatment. It uses circular RNA biomarkers to offers a enrichment in neural tissue, allowing for non-invasive, accurate, and dynamic monitoring of brain disorders.
Who invested in Circular Genomics
7 investors across 3 rounds
See all investors in Circular Genomics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Circular Genomics
Who invested in Circular Genomics?
Circular Genomics has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Circular Genomics raised?
Circular Genomics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Circular Genomics last raise money?
Circular Genomics's most recent round on record is a Series A, in Dec 2025.
What does Circular Genomics do?
Based in New Mexico, US, and founded in 2021 by co-founders Nikolaos Mellios, Alexander Hafez, and Kosmas Karadimitriou, Circular Genomics Inc.
Where is Circular Genomics headquartered?
Circular Genomics is headquartered in Albuquerque, US.
Which VCs invest in companies like Circular Genomics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Circular Genomics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Circular Genomics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.